Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mahler

Showing results (161-170 of 202) with videos related to

Pageof 21
Sort By:
Clinical Chemistry and Laboratory Medicine|July 30, 2017
PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitisMichael Mahler, Jan Damoiseaux, Vera Ballet, et al.
Immunological Investigations|August 13, 2019
Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead ImmunoassaysValentina Grossi, Maria Infantino, Maurizio Benucci, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitisEwa Wunsch, Gary L Norman, Malgorzata Milkiewicz, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseasesOra Shovman, Boris Gilburd, Chen Chayat, et al.
Frontiers in Immunology|April 27, 2019
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body MyositisAdam Amlani, May Y Choi, Mark Tarnopolsky, et al.
Autoimmunity Reviews|August 18, 2020
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndromeSavino Sciascia, Massimo Radin, Carlos Ramirez, et al.
Arthritis Research & Therapy|May 23, 2016
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriersDirk Roggenbuck, Maria Orietta Borghi, Valentina Somma, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Frontiers in Immunology|April 20, 2019
The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center StudyGary L Norman, Anna Reig, Odette Viñas, et al.
Pageof 21

Showing results (161-170 of 202) with videos related to

Sort By:
Pageof 21
Clinical Chemistry and Laboratory Medicine|July 30, 2017
PR3-anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitisMichael Mahler, Jan Damoiseaux, Vera Ballet, et al.
Immunological Investigations|August 13, 2019
Two Novel Technologies for the Detection of Anti-cardiolipin and Anti β2-Glycoprotein Antibodies in the Real Life: Chemiluminescent in Comparison to the Addressable Laser Bead ImmunoassaysValentina Grossi, Maria Infantino, Maurizio Benucci, et al.
Alimentary Pharmacology & Therapeutics|November 7, 2020
Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitisEwa Wunsch, Gary L Norman, Malgorzata Milkiewicz, et al.
Clinical and Experimental Rheumatology|August 4, 2017
Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseasesOra Shovman, Boris Gilburd, Chen Chayat, et al.
Frontiers in Immunology|April 27, 2019
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body MyositisAdam Amlani, May Y Choi, Mark Tarnopolsky, et al.
Autoimmunity Reviews|August 18, 2020
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndromeSavino Sciascia, Massimo Radin, Carlos Ramirez, et al.
Arthritis Research & Therapy|May 23, 2016
Antiphospholipid antibodies detected by line immunoassay differentiate among patients with antiphospholipid syndrome, with infections and asymptomatic carriersDirk Roggenbuck, Maria Orietta Borghi, Valentina Somma, et al.
Rheumatology (Oxford, England)|January 27, 2021
Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritisCeline Lamacchia, Delphine S Courvoisier, Matthias Jarlborg, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 6, 2015
Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndromeLaura Andreoli, Cecilia B Chighizola, Cecilia Nalli, et al.
Frontiers in Immunology|April 20, 2019
The Prevalence of Anti-Hexokinase-1 and Anti-Kelch-Like 12 Peptide Antibodies in Patients With Primary Biliary Cholangitis Is Similar in Europe and North America: A Large International, Multi-Center StudyGary L Norman, Anna Reig, Odette Viñas, et al.
Pageof 21